Suppr超能文献

对一个黑色素瘤家族中痣表型的纵向评估。

Longitudinal assessment of the nevus phenotype in a melanoma kindred.

作者信息

Florell Scott R, Meyer Laurence J, Boucher Kenneth M, Porter-Gill Patricia A, Hart Marybeth, Erickson Jennica, Cannon-Albright Lisa A, Pershing Lynn K, Harris Ronald M, Samlowski Wolfram E, Zone John J, Leachman Sancy A

机构信息

The Melanoma Program, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112-5550, USA.

出版信息

J Invest Dermatol. 2004 Sep;123(3):576-82. doi: 10.1111/j.0022-202X.2004.23312.x.

Abstract

Phenotypic characteristics of members of a melanoma prone kindred with a V126D CDKN2A gene mutation were monitored over approximately 15 y. Thirty-eight previously studied subjects were recruited. Participants underwent a complete skin examination by the same dermatologist who examined them initially. The size and location of all nevi were recorded on a body map diagram. Total nevus number (TNN) and total nevus density (TND) were determined. CDKN2A sequencing verified 13 mutation carriers and 16 non-carriers. Nine participants were spouse controls without a history of melanoma and did not carry a CDKN2A mutation. Mutation carriers demonstrated a greater mean TNN and TND at initial and follow-up examinations compared with non-carriers and continued to develop nevi rather than show nevus regression seen in non-carriers and spouse controls. Non-carriers showed an intermediate nevus phenotype between mutation carriers and spouse controls. Four of the 13 mutation carriers and one non-carrier have developed invasive melanoma. Over a 15-y interval, TNN and TND were increased in mutation carriers compared with non-carriers and spouse controls. Continued accumulation of nevi in mutation carriers supports a nevogenic role for this CDKN2A mutation. An intermediate nevus phenotype in non-carrier family members suggests the presence of additional modifier genes.

摘要

对一个携带V126D CDKN2A基因突变的黑色素瘤易感家族成员的表型特征进行了约15年的监测。招募了38名之前已接受研究的受试者。参与者由最初检查他们的同一位皮肤科医生进行全面的皮肤检查。所有痣的大小和位置都记录在人体地图上。确定了痣总数(TNN)和总痣密度(TND)。CDKN2A基因测序验证了13名突变携带者和16名非携带者。9名参与者为配偶对照,无黑色素瘤病史且不携带CDKN2A突变。与非携带者相比,突变携带者在初次和随访检查时的平均TNN和TND更高,并且继续出现新痣,而非像非携带者和配偶对照那样出现痣消退。非携带者表现出介于突变携带者和配偶对照之间的中间痣表型。13名突变携带者中的4名和1名非携带者已发展为侵袭性黑色素瘤。在15年的时间间隔内,与非携带者和配偶对照相比,突变携带者的TNN和TND有所增加。突变携带者中痣的持续积累支持了这种CDKN2A突变的致痣作用。非携带者家族成员中的中间痣表型表明存在其他修饰基因。

相似文献

1
Longitudinal assessment of the nevus phenotype in a melanoma kindred.
J Invest Dermatol. 2004 Sep;123(3):576-82. doi: 10.1111/j.0022-202X.2004.23312.x.
2
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Melanoma Res. 2010 Aug;20(4):266-72. doi: 10.1097/CMR.0b013e3283341339.
3
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
JAMA Dermatol. 2016 Apr;152(4):405-12. doi: 10.1001/jamadermatol.2015.4356.
4
Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
J Invest Dermatol. 2008 Aug;128(8):2122-5. doi: 10.1038/jid.2008.51. Epub 2008 Mar 13.
5
Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds.
J Natl Cancer Inst. 1991 Dec 4;83(23):1726-33. doi: 10.1093/jnci/83.23.1726.
6
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28.
7
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
J Invest Dermatol. 2000 Jan;114(1):28-33. doi: 10.1046/j.1523-1747.2000.00823.x.
9
Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation.
J Invest Dermatol. 2005 Dec;125(6):1310-2. doi: 10.1111/j.0022-202X.2005.23945.x.
10
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

引用本文的文献

1
Paradigm of biomarkers in metastatic melanoma (Review).
Oncol Lett. 2024 Nov 26;29(2):78. doi: 10.3892/ol.2024.14824. eCollection 2025 Feb.
2
4
Current Molecular Markers of Melanoma and Treatment Targets.
Int J Mol Sci. 2020 May 16;21(10):3535. doi: 10.3390/ijms21103535.
5
Cutaneous melanoma primary site is linked to nevus density.
Oncotarget. 2017 Oct 24;8(58):98876-98886. doi: 10.18632/oncotarget.22016. eCollection 2017 Nov 17.
6
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.
7
Melanocytic nevi and melanoma: unraveling a complex relationship.
Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12.
8
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.
Annu Rev Pathol. 2014;9:239-71. doi: 10.1146/annurev-pathol-012513-104658.
9
Nevus senescence.
ISRN Dermatol. 2011;2011:642157. doi: 10.5402/2011/642157. Epub 2011 Jun 22.
10
Melanoma genetics and the development of rational therapeutics.
J Clin Invest. 2005 Apr;115(4):813-24. doi: 10.1172/JCI24808.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验